Placebo to Match GSK3965193 Tablets clinical trials

Four-part, Randomized, Double-blind (Parts 1, 2A, 3 and 4), Multi-center, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK3965193 Monotherapy in Healthy Participants and in Participants Living with Chronic Hepatitis B Infection; and GSK3965193 in Combination with Bepirovirsen in Participants Living with Chronic Hepatitis B Infection

This study is testing a new medicine, GSK3965193, for people with chronic hepatitis B. We want to see if it's safe, how it works, and if it can help reduce the virus, especially when combined with another treatment called bepirovirsen.